Roux-en-Y Gastric Bypass Improves Hepatic Glucose Metabolism Involving Upregulation of Sirt1 in Type 2 Diabetes Mellitus

BACKGROUND: Roux-en-Y gastric bypass (RYGB) is the most effective treatment for type 2 diabetes mellitus (T2DM). Previous studies have reported that silent information regulator 1 (Sirt1) closely relates to many pathological processes of glucose metabolism and insulin resistance (IR). However, it is...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Chunjie, Cheng, Qian, Wang, Liyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145911/
https://www.ncbi.nlm.nih.gov/pubmed/34045876
http://dx.doi.org/10.2147/DMSO.S298897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8145911/
https://www.ncbi.nlm.nih.gov/pubmed/34045876
http://dx.doi.org/10.2147/DMSO.S298897

Ejemplares similares